Seeking Alpha

BridgeBio Shares Recurrent Event Analysis of ATTRibute-CM, Demonstrating a 42% Reduction by Acoramidis on the Composite Endpoint of All-Cause Mortality and Recurrent ...

- Acoramidis treatment led to a highly significant reduction in all-cause mortality (ACM) and recurrent cardiovascular-related hospitalizations (CVH) at Month 30 compared with placebo - Additionally, ...
Healio

First, recurrent tachycardia less likely in women vs. men with primary prevention ICD

Please provide your email address to receive an email when new articles are posted on . Women with HF who received an implantable cardioverter defibrillator for primary prevention were less likely to ...